NALFON- fenoprofen calcium tablet, film coated

国: アメリカ合衆国

言語: 英語

ソース: NLM (National Library of Medicine)

有効成分:

FENOPROFEN CALCIUM (UNII: 0X2CW1QABJ) (FENOPROFEN - UNII:RA33EAC7KY)

から入手可能:

Xspire Pharma, LLC

投与経路:

ORAL

処方タイプ:

PRESCRIPTION DRUG

適応症:

Carefully consider the potential benefits and risks of NALFON tablets, USP and other treatment options before deciding to use NALFON tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). NALFON tablets are indicated: - For relief of mild to moderate pain in adults. - For relief of the signs and symptoms of rheumatoid arthritis. - For relief of the signs and symptoms of osteoarthritis. NALFON tablets are contraindicated in patients who have shown hypersensitivity to fenoprofen calcium. NALFON tablets should not be given to patients who have experienced asthma, urticaria or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients (see WARNINGS: Anaphylactoid Reactions,and PRECAUTIONS: Preexisting Asthma). NALFON is contraindicated in the setting of coronary artery bypass graft (CABG) surgery (see WARNINGS). NALFON is co

製品概要:

NALFON (fenoprofen calcium tablets), USP are available containing fenoprofen calcium, USP equivalent to 600 mg fenoprofen. The 600 mg tablet is an orange film-coated, capsule-shaped tablet debossed with "600" on one side of the tablet and scored on the other side. They are available as follows: NDC 42195-688-10 bottles of 100 tablets Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from light. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. PHARMACIST: Dispense a Medication Guide with each prescription.

認証ステータス:

Abbreviated New Drug Application

情報リーフレット

Xspire Pharma, LLC
----------
MEDICATION GUIDE FOR NONSTEROIDAL
ANTI-INFLAMMATORY DRUGS (NSAIDS )
What is the most important information I should know about medicines
called Nonsteroidal Anti-
inflammatoryDrugs (NSAIDs)?
NSAIDs can cause serious side effects, including:
•
Increased risk of a heart attack or stroke that can lead to death.This
risk may happen early in
treatment and may increase:
•
with increasing doses of NSAIDs
•
with longer use of NSAIDs
Do not take NSAIDs right before or after a heart surgery called a
“coronary artery bypass graft (CABG)."
Avoid taking NSAIDs after a recent heart attack, unless your
healthcare provider tells you to. You may
have an increased risk of another heart attack if you take NSAIDs
after a recent heart attack .
•
Increased risk of bleeding, ulcers, and tears (perforation) of the
esophagus (tube leading from the
mouth to the stomach), stomach and intestines:
•
anytime during use
•
without warning symptoms
•
that may cause death
•
The risk of getting an ulcer or bleeding increases with:
•
past history of stomach ulcers, or stomach or intestinal bleeding with
use of NSAID
•
taking medicines called “corticosteroids”, “anticoagulants”,
“SSRIs”, or “SNRIs”
•
increasing doses of NSAIDs
•
older age
•
longer use of NSAIDs
•
poor health
•
smoking
•
advanced liver disease
•
drinking alcohol
•
bleeding problems
•
NSAIDs should only be used:
•
exactly as prescribed
•
at the lowest dose possible for your treatment
•
for the shortest time needed
What are NSAIDs?
NSAIDs are used to treat pain and redness, swelling, and heat
(inflammation) from medical conditions
such as different types of arthritis, menstrual cramps, and other
types of short-term pain.
Who should not take NSAIDs?
Do not take NSAIDs:
•
if you have had an asthma attack, hives, or other allergic reaction
with aspirin or any other
NSAIDs.
•
right before or after heart bypass surgery.
Before taking NSAIDs, tell your healthcare provider about all of your
medical

製品の特徴

NALFON- FENOPROFEN CALCIUM TABLET, FILM COATED
XSPIRE PHARMA, LLC
----------
NALFON
(FENOPROFEN CALCIUM TABLETS, USP)
CARDIOVASCULAR THROMBOTIC EVENTS
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) CAUSE AN INCREASED
RISK OF SERIOUS CARDIOVASCULAR THROMBOTIC EVENTS, INCLUDING MYOCARDIAL
INFARCTION AND STROKE, WHICH CAN BE FATAL. THIS RISK MAY OCCUR EARLY
IN
TREATMENT AND MAY INCREASE WITH DURATION OF USE (SEE WARNINGSAND
PRECAUTIONS).
FENOPROFEN CALCIUM TABLETS ARE CONTRAINDICATED IN THE SETTING OF
CORONARY ARTERY BYPASS GRAFT (CABG) SURGERY (SEE
CONTRAINDICATIONSAND WARNINGS).
GASTROINTESTINAL RISK
NSAIDS CAUSE AN INCREASED RISK OF SERIOUS GASTROINTESTINAL ADVERSE
EVENTS INCLUDING BLEEDING, ULCERATION AND PERFORATION OF STOMACH OR
INTESTINES, WHICH CAN BE FATAL. THESE EVENTS CAN OCCUR AT ANY TIME
DURING USE AND WITHOUT WARNING SYMPTOMS. ELDERLY PATIENTS ARE AT
GREATER RISK FOR SERIOUS GASTROINTESTINAL EVENTS (SEE WARNINGS).
DESCRIPTION
NALFON
(fenoprofen calcium tablets) USP is a nonsteroidal, anti-inflammatory,
antiarthritic drug. Chemically, fenoprofen calcium is an arylacetic
acid derivative. The
structural formula is as follows:
BENZENEACETIC ACID, Α-METHYL-3-PHENOXY-, CALCIUM SALT (2:1)-(±)-,
DIHYDRATE
Fenoprofen calcium, USP is a white crystalline powder, soluble in
alcohol (95%) to the
extent of approximately 15 mg/mL at 25°C, slightly soluble in water
and insoluble in
benzene.
The pKa of fenoprofen calcium is 4.5 at 25°C.
Film-coated NALFON tablets for oral administration are available
containing fenoprofen
calcium as the dihydrate equivalent to 600 mg of fenoprofen and the
following inactive
ingredients: colloidal silicon dioxide, croscarmellose sodium,
hypromellose, magnesium
stearate, microcrystalline cellulose, polyethylene glycol, polysorbate
80, pregelatinized
starch, sodium lauryl sulfate, titanium dioxide and FD&C Yellow No. 6
Aluminum Lake.
®
®
CLINICAL PHARMACOLOGY
NALFON
tablets is a nonsteroidal, anti-inflammatory, antiarthritic drug that
also
possesses analgesic and antipyretic activiti